Evidence map›Paper›PMID 35435754›Full record

ArticleMicrobiology spectrum2022

An E3 Ubiquitin Ligase Scaffolding Protein Is Proviral during Chikungunya Virus Infection in Aedes aegypti.

Sunil Kumar Dubey, Divya Mehta, Sakshi Chaudhary, Abdul Hasan, Sujatha Sunil

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sunil Kumar Dubey *Vector Borne Disease Group, International Centre for Genetic Engineering and Biotechnologygrid.425195.e (ICGEB), New Delhi, India.
Divya Mehta *Vector Borne Disease Group, International Centre for Genetic Engineering and Biotechnologygrid.425195.e (ICGEB), New Delhi, India.
Sakshi ChaudharyVector Borne Disease Group, International Centre for Genetic Engineering and Biotechnologygrid.425195.e (ICGEB), New Delhi, India.
Abdul HasanVector Borne Disease Group, International Centre for Genetic Engineering and Biotechnologygrid.425195.e (ICGEB), New Delhi, India.
Sujatha SunilVector Borne Disease Group, International Centre for Genetic Engineering and Biotechnologygrid.425195.e (ICGEB), New Delhi, India.ORCID 0000-0002-6531-7768
International Centre for Genetic Engineering and Biotechnology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chikungunya virus (CHIKV) is a reemerging alphavirus causing chikungunya disease (CHIKD) and is transmitted to humans by

Indexed as

AedesChikungunya FeverChikungunya virusAnimalsDrosophilaMosquito VectorsProvirusesUbiquitin-Protein LigasesUbiquitinsUbiquitin-Protein LigasesUbiquitinsAedes aegyptiChikungunya virusubiquitin proteasomal pathwayvector–virus interactions

Identifiers

PMID35435754
PMCPMC9241663
OpenAlexW4223904904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.